Intra-cellular therapies to present at the 6th annual evercore isi healthconx conference

New york, nov. 15, 2023 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced that it will present at the 6th annual evercore isi healthconx conference on tuesday, november 28, 2023 at 3:25 p.m. et in miami, fl.
ITCI Ratings Summary
ITCI Quant Ranking